ARCHIVES

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

This article is from The Cancer Letter archive.

Vol. 39 No. 39 | October 18, 2013

Download PDF Visit The Full Archive

Related Articles

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

Evidence Links Anemia Drugs With Leukemic Transformation

December 28, 2007